645 related articles for article (PubMed ID: 27098360)
1. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
3. Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for their first episode of acute heart failure.
Londoño KL; Formiga F; Chivite D; Moreno-Gonzalez R; Migone De Amicis M; Corbella X
Intern Emerg Med; 2018 Apr; 13(3):351-357. PubMed ID: 29508227
[TBL] [Abstract][Full Text] [Related]
4. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T
Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135
[TBL] [Abstract][Full Text] [Related]
6. Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization.
Horne BD; Budge D; Masica AL; Savitz LA; Benuzillo J; Cantu G; Bradshaw A; McCubrey RO; Bair TL; Roberts CA; Rasmusson KD; Alharethi R; Kfoury AG; James BC; Lappé DL
Am Heart J; 2017 Mar; 185():101-109. PubMed ID: 28267463
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and management of COPD and heart failure comorbidity in the general practitioner setting.
Pirina P; Martinetti M; Spada C; Zinellu E; Pes R; Chessa E; Fois AG; Miravitlles M;
Respir Med; 2017 Oct; 131():1-5. PubMed ID: 28947013
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
[TBL] [Abstract][Full Text] [Related]
9. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
[TBL] [Abstract][Full Text] [Related]
10. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
11. Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure - A danish nationwide registry-based study.
Andersson C; Hansen PW; Steffensen IE; Andreasen C; Weeke PE; Køber L; Gislason GH; Torp-Pedersen C
Eur J Intern Med; 2019 May; 63():56-61. PubMed ID: 30833208
[TBL] [Abstract][Full Text] [Related]
12. Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
Kruik-Kollöffel WJ; van der Palen J; Doggen CJM; van Maaren MC; Kruik HJ; Heintjes EM; Movig KLL; Linssen GCM
PLoS One; 2020; 15(12):e0244231. PubMed ID: 33351823
[TBL] [Abstract][Full Text] [Related]
13. CORT-AHF Study: Effect on Outcomes of Systemic Corticosteroid Therapy During Early Management Acute Heart Failure.
Miró Ò; Takagi K; Gayat E; Llorens P; Martín-Sánchez FJ; Jacob J; Herrero-Puente P; Gil V; Wussler DN; Richard F; López-Grima ML; Gil C; Garrido JM; Pérez-Durá MJ; Alquézar A; Alonso H; Tost J; Lucas Invernón FJ; Mueller C; Mebazaa A
JACC Heart Fail; 2019 Oct; 7(10):834-845. PubMed ID: 31521676
[TBL] [Abstract][Full Text] [Related]
14. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
[TBL] [Abstract][Full Text] [Related]
16. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
17. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
18. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
19. Changes in Drug Utilization and Outcome With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.
Penn J; Goldenberg I; McNitt S; Polonsky B; Ruwald MH; Zareba W; Moss AJ; Alexis JD
J Card Fail; 2015 Jul; 21(7):541-7. PubMed ID: 25800548
[TBL] [Abstract][Full Text] [Related]
20. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
